B. Riley Wealth Advisors Inc. Sells 1,793 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

B. Riley Wealth Advisors Inc. lessened its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 31.6% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,877 shares of the medical equipment provider's stock after selling 1,793 shares during the period. B. Riley Wealth Advisors Inc.'s holdings in Intuitive Surgical were worth $1,892,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in the company. Hennion & Walsh Asset Management Inc. grew its holdings in shares of Intuitive Surgical by 12.6% during the second quarter. Hennion & Walsh Asset Management Inc. now owns 8,765 shares of the medical equipment provider's stock valued at $3,899,000 after purchasing an additional 980 shares during the last quarter. Apollon Wealth Management LLC increased its position in Intuitive Surgical by 3.2% in the second quarter. Apollon Wealth Management LLC now owns 10,308 shares of the medical equipment provider's stock worth $4,586,000 after buying an additional 315 shares during the period. Continuum Advisory LLC lifted its stake in Intuitive Surgical by 14.7% in the second quarter. Continuum Advisory LLC now owns 375 shares of the medical equipment provider's stock valued at $167,000 after buying an additional 48 shares during the last quarter. First Horizon Advisors Inc. grew its position in shares of Intuitive Surgical by 2.2% during the second quarter. First Horizon Advisors Inc. now owns 6,389 shares of the medical equipment provider's stock worth $2,842,000 after acquiring an additional 140 shares during the last quarter. Finally, Dakota Wealth Management increased its holdings in shares of Intuitive Surgical by 48.4% in the 2nd quarter. Dakota Wealth Management now owns 13,474 shares of the medical equipment provider's stock worth $5,994,000 after acquiring an additional 4,396 shares during the period. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Price Performance

Shares of ISRG traded up $2.41 during trading hours on Monday, hitting $541.99. 1,534,715 shares of the company were exchanged, compared to its average volume of 1,439,932. The firm has a fifty day simple moving average of $521.82 and a 200-day simple moving average of $479.57. The company has a market capitalization of $193.05 billion, a PE ratio of 86.75, a PEG ratio of 5.35 and a beta of 1.38. Intuitive Surgical, Inc. has a one year low of $320.26 and a one year high of $556.23.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping analysts' consensus estimates of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The firm had revenue of $2.04 billion for the quarter, compared to analysts' expectations of $2.01 billion. Sell-side analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Insider Activity

In related news, EVP Robert Desantis sold 188 shares of the firm's stock in a transaction that occurred on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total transaction of $95,225.76. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,788,899.12. This trade represents a 3.30 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP Mark Brosius sold 2,128 shares of the company's stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the completion of the transaction, the senior vice president now owns 273 shares in the company, valued at approximately $140,595. This represents a 88.63 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 48,190 shares of company stock worth $25,012,927 over the last 90 days. 0.90% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of research analysts have issued reports on ISRG shares. Evercore ISI reissued a "cautious" rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Morgan Stanley raised Intuitive Surgical from an "equal weight" rating to an "overweight" rating and increased their price objective for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. Piper Sandler reaffirmed an "overweight" rating and set a $538.00 target price (up previously from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. Erste Group Bank upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Tuesday, November 19th. Finally, BTIG Research lifted their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a "buy" rating in a research note on Tuesday, November 26th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $550.28.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.